Find our playbooks, ai models, articles about the medtech, and guest blogs here, updated weekly.

Six exits. $17 billion combined. The founders who built them share seven lessons most medtech founders learn too late.

MAKO Surgical was one of the most-shorted stocks on Wall Street. Stryker paid $1.65B for it anyway. Here's how Rony Abovitz built a category nobody believed in.

Most medtech founders hire a sales team right after FDA clearance. Bruce Cleveland spent 20 years in venture watching that fail.

Ray Cohen ran 20 consecutive quarters beating analyst expectations before Boston Scientific acquired Axonics for $3.7B.

Hosting the State of Medtech podcast I noticed a common theme as I interviewed founders, VCs, and strategics.